BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7083732)

  • 21. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats.
    Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ
    Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indoramin, a drug with prevalent antihypertensive activity: experimental study].
    Marmo E; Rossi F; Caputi AP; Lampa E; Petrarca R; Ottavo R
    Clin Ter; 1979 Feb; 88(3):233-62. PubMed ID: 445975
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of propranolol on hemodynamic shifts and respiration during physical exertion in patients with hypertensive disease].
    Glezer GA; Moskalenko NP; Megrelishvili RI; Zil'bert NL
    Kardiologiia; 1975 Mar; 15(3):60-5. PubMed ID: 1142612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of indoramin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Feb; 144(2):308-12. PubMed ID: 6696567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
    Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
    Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenoceptor blockade and cardiovascular response to the cold pressor test.
    Dikshit MB; Patrick JM
    Indian J Physiol Pharmacol; 1986; 30(1):1-10. PubMed ID: 3818024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
    Bache RJ; Homans DC; Schwartz JS; Dai XZ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):232-7. PubMed ID: 2896237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.
    Velasco M; Romero E; Bertoncini H; Urbina-Quintana A; Guevara J; Hernández-Pieretti O
    Br J Clin Pharmacol; 1978 Sep; 6(3):217-20. PubMed ID: 687499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
    McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
    J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the renal effects of indoramin and prazosin.
    Strandhoy JW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S151-5. PubMed ID: 2423789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.
    Pandhi P; Sharma PL; Sharma BK; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):249-53. PubMed ID: 3525424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive therapy with indoramin in the elderly.
    Deitch MW; Allen IE; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.